Skip to main content
Clinical Trials/ACTRN12624000276550
ACTRN12624000276550Not yet recruitingPhase 1

Safety and efficacy of Eucalypt sap resin for inflammatory skin conditions and wound care in adults – An exploratory case series

Integria Healthcare (Australia) Pty Ltd.0 sites60 target enrollmentStarted: March 18, 2024Last updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 70 Years (—)
Sex
All

Inclusion Criteria

  • Adult males and females
  • Presence of inflammatory skin condition or wound

Exclusion Criteria

  • - Pregnant, planning pregnancy or breastfeeding
  • - Any clinically relevant abnormal findings which, in the opinion of the Investigators may put the participant at risk of adverse events due to participation in clinical trial.
  • - Use of any topical or oral anti-microbial, anti-fungal, anti-acne, or steroid medicated treatments in the previous 3 days

Investigators

Similar Trials